Early prediction of treatment outcome for lenvatinib using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, non-randomised study.

Saved in:
Bibliographic Details
Title: Early prediction of treatment outcome for lenvatinib using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, non-randomised study.
Authors: Takeuchi, Satoshi1 (AUTHOR) stakeuch@med.hokudai.ac.jp, Hirata, Kenji2 (AUTHOR), Magota, Keiichi3 (AUTHOR), Watanabe, Shiro4 (AUTHOR), Moku, Rika1 (AUTHOR), Shiiya, Akihiko1 (AUTHOR), Taguchi, Jun1 (AUTHOR), Ariga, Shin1 (AUTHOR), Goda, Tomohiro1 (AUTHOR), Ohhara, Yoshihito1 (AUTHOR), Noguchi, Takurou1 (AUTHOR), Shimizu, Yasushi1 (AUTHOR), Kinoshita, Ichiro1 (AUTHOR), Honma, Rio5 (AUTHOR), Tsuji, Yasushi5 (AUTHOR), Homma, Akihiro6 (AUTHOR), Dosaka-Akita, Hirotoshi1 (AUTHOR)
Source: EJNMMI Research. 7/17/2023, Vol. 13 Issue 1, p1-9. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:2191219X
DOI:10.1186/s13550-023-01019-9